Clinical Trial Update: Accelerated rTMS for Treatment-Resistant Major Depression [Phase 2, Phase 3]

View source ↗

Summary

Phase 2 and Phase 3 trials evaluating accelerated repetitive transcranial magnetic stimulation for treatment-resistant major depressive disorder have completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Accelerated rTMS device

Snippet

Sponsor: Douglas Mental Health University Institute | Conditions: Major Depressive Disorder | Phase 2, Phase 3 | Status: COMPLETED